Magdalena Bialon
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Preclinical characterization of the efficacy and safety of histamine H3 receptor antagonist, LINS01022, as a novel analgesic for chronic neuropathic pain treatment.
Journal: European journal of pharmacology
Published: February 17, 2026
Cannabidiol in Neurology: Current Insights and Translational Perspectives.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 17, 2025
Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 18, 2024
Network analysis of monoamines involved in anxiety-like behavior in a rat model of osteoarthritis.
Journal: Pharmacological reports : PR
Published: September 30, 2023
Advantages and Limitations of Animal Schizophrenia Models.
Journal: International journal of molecular sciences
Published: April 21, 2022
The Impact of the Combined Administration of 1MeTIQ and MK-801 on Cell Viability, Oxidative Stress Markers, and Glutamate Release in the Rat Hippocampus.
Journal: Neurotoxicity research
Published: September 03, 2021
1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia.
Journal: Pharmacological reports : PR
Published: September 18, 2020
Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex.
Journal: Behavioural brain research
Published: December 16, 2019
Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects.
Journal: Psychopharmacology
Published: November 19, 2019
Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment.
Journal: Pharmacology, biochemistry, and behavior
Published: January 22, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026